Exclusive special offer and discount title banner vector image

GLOBAL COUGH SYRUP MARKET FORECAST 2023-2032

SCOPE OF THE REPORT

Global Cough Syrup Market by Product Type (Cough Suppressants, Combination Medicines, Expectorants) Market by Age Group (Adults, Adolescents, Pediatric) Market by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-pharmacies) by Geography

REQUEST CUSTOMIZATION

MARKET OVERVIEW

The global cough syrup market is expected to reach $8105.18 million by 2032, growing at a CAGR of 3.62% during the forecast period, 2023-2032. 

Cough syrups, a category of pharmaceutical formulations, are liquid medications primarily designed to alleviate symptoms associated with common respiratory conditions. These formulations serve as remedies for coughs, sore throats, and related discomforts arising from ailments like the common cold, influenza, allergies, and various respiratory infections.

Cough syrups often contain active ingredients such as antitussives to suppress coughing, expectorants to facilitate mucus clearance, and soothing agents like honey or menthol. Available in a variety of formulations tailored for different age groups, including adults, children, and infants, cough syrups are a popular choice for individuals seeking relief from the irritation and distress caused by respiratory symptoms.

COUGH SYRUP MARKET

Read our latest blog on the Cough Syrup Market

GROWTH ENABLERS

Key growth enablers of the global cough syrup market are:

  • Prevalence of respiratory ailments
    • Respiratory ailments, ranging from common colds and flu to more chronic conditions like bronchitis and asthma, affect a substantial portion of the population worldwide. As per Eurostat, respiratory ailments like chronic obstructive pulmonary disease, asthma, pneumonia, etc., are the main causes of mortality in the European Union.
    • Similarly, chronic lower respiratory diseases, especially chronic obstructive pulmonary disease (COPD), is the United States’ fourth biggest cause of mortality. COPD affects around 15.7 million Americans (6.4%).
    • Further, manufacturers often highlight their products’ effectiveness in managing coughs associated with common respiratory conditions, leveraging the widespread understanding of these health issues among consumers.
  • Rising geriatric population
  • Innovations in cough syrups

GROWTH RESTRAINTS

Key factors restraining the global cough syrup market growth are:

  • Over-dosage concerns driving consumers toward alternatives
    • Overdosing cough syrups, like any medication, can lead to a range of adverse effects that can vary in severity depending on the active ingredients and the quantity consumed. Overdose symptoms might include dizziness, drowsiness, confusion, rapid heart rate, breathing difficulties, nausea, vomiting, and even more serious complications such as seizures or cardiac issues.
    • For instance, according to the American Addiction Center, dextromethorphan is habit-forming and intoxicating. It is a dangerous narcotic whose excessive consumption can result in a fatal overdose.
    • Also, there has been a rise in alternative cough relief products. Herbal remedies, throat lozenges, steam inhalation, and saline nasal sprays are among the few examples of alternatives that consumers turn to. Moreover, these options offer relief from cough and cold symptoms and are generally considered safer and less likely to be abused.
  • Stringent regulatory protocols 
  • Increasing cases of cough syrup deaths

To Know More About This Report, Request a Free Sample Copy

KEY MARKET TRENDS

Global Cough Syrup Market | Key Market Trends

  • There has been a notable shift toward herbal cough syrups, largely influenced by several cases of deaths and health complications associated with traditional cough syrups, for instance, overdosage or the presence of toxic ingredients. Herbal cough syrups, typically made from a blend of plant-based ingredients, are perceived to carry fewer risks of adverse reactions and complications compared to their synthetic counterparts.
  • The convenience, accessibility, and wide array of options offered by online platforms have reshaped consumer buying habits and are expected to profoundly impact the way cough syrups are bought and sold. Consumers can now browse, compare, and purchase a variety of cough syrups from the comfort of their homes, eliminating the need to visit physical stores. These platforms offer a vast selection of cough syrups, enabling consumers to explore a wider range of products than they might find at their local pharmacies.
  • The upward surge in self-medication trends has significantly influenced the global cough syrup market dynamics, leading to a noticeable increase in demand for over-the-counter (OTC) cough syrups. This is attributed to a combination of factors, including growing familiarity with OTC medications, the convenience of easy access, and the desire for immediate relief from common cold and cough symptoms.

MARKET SEGMENTATION

Market Segmentation – Product Type, Age Group, and Distribution Channel

Market by Product Type: 

  • Cough Suppressants
    • Cough suppressants are the dominating product type in the global cough syrup market. 
    • Cough suppressants’ availability as over-the-counter (OTC) drugs is crucial in generating a high demand. Accordingly, they are easily purchased and used for self-medication since OTC drugs are readily available to consumers without needing a prescription. This has further helped its widespread use and the subsequent high demand for cough suppressants.
    • Further, the fast-paced nature of modern life has resulted in a culture of quick solutions and instant gratification. This trend is largely supported by over-the-counter cough suppressants. Cough suppressants, designed to provide immediate and focused symptom alleviation, fit into this narrative, adding to their popularity.
  • Combination Medicines
  • Expectorants

Market by Age Group:

  • Adults
    • Adults are the fastest-growing age group segment in the global cough syrup market.
    • The immune system weakens with age, making it more vulnerable to respiratory illnesses such as the common cold, flu, or bronchitis. Adults are frequently exposed to environmental contaminants and allergies. They may be exposed to dust, chemicals, or pollutants in occupational settings such as offices or factories, making them more susceptible to coughing.
    • Further, adults are more likely to have underlying chronic health disorders such as asthma, COPD, or gastroesophageal reflux disease (GERD). These illnesses can cause persistent coughing and may necessitate the use of cough syrups regularly to reduce symptoms and enhance the quality of life. For instance, according to the American Lung Association, in 2020, COPD was diagnosed in 12.5 million persons, or 5.0% of adults.
  • Adolescents
  • Pediatric

Market by Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • E-Pharmacies

GEOGRAPHICAL STUDY

Geographical Study based on Four Major Regions: 

  • Europe: The United Kingdom, France, Germany, Spain, Italy, Poland, Belgium, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
    • Asia-Pacific is the fastest-growing region in the global cough syrup market.
    • In countries like China, COVID-19 prompted panic buying and increased consumer demand for various healthcare products, including cough syrups. Concerns about respiratory symptoms led to surging purchases as individuals sought relief from common cold and flu symptoms.
    • In the case of Japan, the government’s commitment to affordable healthcare plays a pivotal role in driving the demand for cough syrups. Japan has a robust national healthcare policy that emphasizes keeping healthcare products, including medications, affordable and accessible to all citizens. Similarly, the government actively regulates drug prices, encourages the use of generic medications, and negotiates with pharmaceutical companies to control healthcare costs.
    • Furthermore, Japan’s unique demographic profile, characterized by the highest geriatric population in the world, with approximately 28% of its people aged above 65, has a significant impact on the demand for healthcare products, including cough syrups.
  • Rest of World: Latin America and the Middle East & Africa

MAJOR PLAYERS

The major players in the global cough syrup market are:

  • GSK plc
  • Reckitt Benckiser Group PLC
  • Pfizer Inc
  • Novartis AG
  • Procter & Gamble
  • Cipla Ltd

Key strategies adopted by some of these companies:

  • BELLUS Health Inc and GSK plc, in April 2023 announced an agreement under which GSK will buy BELLUS. With the acquisition, GSK now has access to the phase III-tested camlipixant P2X3 antagonist being developed for the first-line management of adult patients with refractory chronic cough.
  • In September 2021, Sun Pharmaceutical Industries Ltd launched Chericof 12. It is made with Polistirex technology for prolonged medication release and is approved for patients aged six and above.
  • In February 2021, Johnson & Johnson completed the acquisition of Zarbee’s Naturals. This acquisition enabled the company to meet the rising demand for cough syrups and diversify its product portfolio.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments AnalyzedProduct Type, Age Group, Distribution Channel
Geographies AnalyzedNorth America, Europe, Asia-Pacific, and Rest of World
Companies Analyzed

Abbott Laboratories, Acella Pharmaceuticals, AstraZeneca Plc, Cipla Ltd, Dabur India Ltd, Glenmark Pharmaceuticals Ltd, GSK plc, Himalaya Wellness Company, Kenvue, Merck KGaA, Novartis AG, Pfizer Inc, Procter & Gamble, Reckitt Benckiser Group PLC, Sanofi

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON COUGH SYRUP MARKET
      2. IMPACT OF THE RUSSIA-UKRAINE WAR ON COUGH SYRUP MARKET
    5. MAJOR MARKET FINDINGS
      1. PRODUCT DIVERSIFICATION IS ON THE RISE
      2. DOMINANCE OF OTC COUGH SYRUPS HAS DRIVEN ACCESSIBILITY
      3. HEALTHCARE INFORMATION AVAILABILITY ON DIGITAL PLATFORMS INFLUENCES CONSUMER CHOICES
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. PREVALENCE OF RESPIRATORY AILMENTS
      2. RISING GERIATRIC POPULATION
      3. INNOVATIONS IN COUGH SYRUPS
    2. KEY RESTRAINTS
      1. OVER-DOSAGE CONCERNS DRIVING CONSUMERS TOWARD ALTERNATIVES
      2. STRINGENT REGULATORY PROTOCOLS
      3. INCREASING CASES OF COUGH SYRUP DEATHS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. INCREASING SELF-MEDICATION TRENDS
      2. SHIFTING CONSUMER PREFERENCE TOWARD HERBAL COUGH SYRUPS
      3. RISING POPULARITY OF E-COMMERCE CHANNELS
      4. COMPANIES ARE OFFERING SUGAR-FREE COUGH SYRUPS
      5. GROWING INCLINATION TOWARD HOMEOPATHIC COUGH SYRUPS
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR UNITED STATES
      2. GROWTH PROSPECT MAPPING FOR ITALY
      3. GROWTH PROSPECT MAPPING FOR JAPAN
      4. GROWTH PROSPECT MAPPING FOR MIDDLE EAST & AFRICA
    4. MARKET MATURITY ANALYSIS
    5. MARKET CONCENTRATION ANALYSIS
    6. VALUE CHAIN ANALYSIS
  5. MARKET BY PRODUCT TYPE
    1. COUGH SUPPRESSANTS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. COMBINATION MEDICINES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. EXPECTORANTS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  6. MARKET BY AGE GROUP
    1. ADULTS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. ADOLESCENTS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. PEDIATRIC
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  7. MARKET BY DISTRIBUTION CHANNEL
    1. RETAIL PHARMACIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. HOSPITAL PHARMACIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. E-PHARMACIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  8. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA COUGH SYRUP MARKET DRIVERS
      3. NORTH AMERICA COUGH SYRUP MARKET CHALLENGES
      4. NORTH AMERICA COUGH SYRUP MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN NORTH AMERICA COUGH SYRUP MARKET
      6. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        2. CANADA
          1. CANADA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. EUROPE COUGH SYRUP MARKET DRIVERS
      3. EUROPE COUGH SYRUP MARKET CHALLENGES
      4. EUROPE COUGH SYRUP MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN EUROPE COUGH SYRUP MARKET
      6. COUNTRY ANALYSIS
        1. UNITED KINGDOM
          1. UNITED KINGDOM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        2. GERMANY
          1. GERMANY COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        3. FRANCE
          1. FRANCE COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        4. ITALY
          1. ITALY COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        5. SPAIN
          1. SPAIN COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        6. POLAND
          1. POLAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        7. BELGIUM
          1. BELGIUM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        8. REST OF EUROPE
          1. REST OF EUROPE COUGH SYRUP MARKET SIZE & OPPORTUNITIES
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC COUGH SYRUP MARKET DRIVERS
      3. ASIA-PACIFIC COUGH SYRUP MARKET CHALLENGES
      4. ASIA-PACIFIC COUGH SYRUP MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN ASIA-PACIFIC COUGH SYRUP MARKET
      6. COUNTRY ANALYSIS
        1. CHINA
          1. CHINA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        2. JAPAN
          1. JAPAN COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        3. INDIA
          1. INDIA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        4. SOUTH KOREA
          1. SOUTH KOREA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        5. INDONESIA
          1. INDONESIA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        6. THAILAND
          1. THAILAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        7. VIETNAM
          1. VIETNAM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        8. AUSTRALIA & NEW ZEALAND
          1. AUSTRALIA & NEW ZEALAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        9. REST OF ASIA-PACIFIC
          1. REST OF ASIA-PACIFIC COUGH SYRUP MARKET SIZE & OPPORTUNITIES
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. REST OF WORLD COUGH SYRUP MARKET DRIVERS
      3. REST OF WORLD COUGH SYRUP MARKET CHALLENGES
      4. REST OF WORLD COUGH SYRUP MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN REST OF WORLD COUGH SYRUP MARKET
      6. REGIONAL ANALYSIS
        1. LATIN AMERICA
          1. LATIN AMERICA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        2. MIDDLE EAST & AFRICA
          1. MIDDLE EAST & AFRICA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. ABBOTT LABORATORIES
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      2. ACELLA PHARMACEUTICALS
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      3. ASTRAZENECA PLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      4. CIPLA LTD
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      5. DABUR INDIA LTD
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      6. GLENMARK PHARMACEUTICALS LTD
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      7. GSK PLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      8. HIMALAYA WELLNESS COMPANY
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      9. KENVUE
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      10. MERCK KGAA
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      11. NOVARTIS AG
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      12. PFIZER INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      13. PROCTER & GAMBLE
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      14. RECKITT BENCKISER GROUP PLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      15. SANOFI
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – COUGH SYRUP MARKET

TABLE 2: GLOBAL COUGH SYRUP MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: GLOBAL COUGH SYRUP MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 4: GLOBAL COUGH SUPPRESSANTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: GLOBAL COUGH SUPPRESSANTS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 6: GLOBAL COMBINATION MEDICINES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7:  GLOBAL COMBINATION MEDICINES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 8: GLOBAL EXPECTORANTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: GLOBAL EXPECTORANTS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 10: GLOBAL COUGH SYRUP MARKET, BY AGE GROUP, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: GLOBAL COUGH SYRUP MARKET, BY AGE GROUP, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 12: GLOBAL ADULTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 13: GLOBAL ADULTS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 14: GLOBAL ADOLESCENTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 15: GLOBAL ADOLESCENTS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 16: GLOBAL PEDIATRIC MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 17: GLOBAL PEDIATRIC MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 18: GLOBAL COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 19: GLOBAL COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 20: GLOBAL RETAIL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 21: GLOBAL RETAIL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 22: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 23: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 24: GLOBAL E-PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 25: GLOBAL E-PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 26: GLOBAL COUGH SYRUP MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 27: GLOBAL COUGH SYRUP MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 28: NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 29: NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 30: NORTH AMERICA COUGH SYRUP MARKET REGULATORY FRAMEWORK

TABLE 31: KEY PLAYERS OPERATING IN NORTH AMERICA COUGH SYRUP MARKET

TABLE 32: EUROPE COUGH SYRUP MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 33: EUROPE COUGH SYRUP MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 34: EUROPE COUGH SYRUP MARKET REGULATORY FRAMEWORK

TABLE 35: KEY PLAYERS OPERATING IN EUROPE COUGH SYRUP MARKET

TABLE 36: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 37: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 38: ASIA-PACIFIC COUGH SYRUP MARKET REGULATORY FRAMEWORK

TABLE 39: KEY PLAYERS OPERATING IN ASIA-PACIFIC COUGH SYRUP MARKET

TABLE 40: REST OF WORLD COUGH SYRUP MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 41: REST OF WORLD COUGH SYRUP MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 42: REST OF WORLD COUGH SYRUP MARKET REGULATORY FRAMEWORK

TABLE 43: KEY PLAYERS OPERATING IN REST OF WORLD COUGH SYRUP MARKET

TABLE 44: LIST OF MERGERS & ACQUISITIONS

TABLE 45: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 46: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 47: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES

FIGURE 4: GROWTH PROSPECT MAPPING FOR ITALY

FIGURE 5: GROWTH PROSPECT MAPPING FOR JAPAN

FIGURE 6: GROWTH PROSPECT MAPPING FOR MIDDLE EAST & AFRICA

FIGURE 7: MARKET MATURITY ANALYSIS

FIGURE 8: MARKET CONCENTRATION ANALYSIS

FIGURE 9: VALUE CHAIN ANALYSIS

FIGURE 10: GLOBAL COUGH SYRUP MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2022

FIGURE 11: GLOBAL COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2032 (IN $ MILLION)

FIGURE 12: GLOBAL COUGH SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2032 (IN $ MILLION)

FIGURE 13: GLOBAL COUGH SYRUP MARKET, BY EXPECTORANTS, 2023-2032 (IN $ MILLION)

FIGURE 14: GLOBAL COUGH SYRUP MARKET, GROWTH POTENTIAL, BY AGE GROUP, IN 2022

FIGURE 15: GLOBAL COUGH SYRUP MARKET, BY ADULTS, 2023-2032 (IN $ MILLION)

FIGURE 16: GLOBAL COUGH SYRUP MARKET, BY ADOLESCENTS, 2023-2032 (IN $ MILLION)

FIGURE 17: GLOBAL COUGH SYRUP MARKET, BY PEDIATRIC, 2023-2032 (IN $ MILLION)

FIGURE 18: GLOBAL COUGH SYRUP MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2022

FIGURE 19: GLOBAL COUGH SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2032 (IN $ MILLION)

FIGURE 20: GLOBAL COUGH SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2032 (IN $ MILLION)

FIGURE 21: GLOBAL COUGH SYRUP MARKET, BY E-PHARMACIES, 2023-2032 (IN $ MILLION)

FIGURE 22: GLOBAL COUGH SYRUP MARKET, BY GEOGRAPHY, 2022 & 2032 (IN %)

FIGURE 23: NORTH AMERICA COUGH SYRUP MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 24: UNITED STATES COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 25: CANADA COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 26: EUROPE COUGH SYRUP MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 27: UNITED KINGDOM COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 28: GERMANY COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 29: FRANCE COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 30: ITALY COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 31: SPAIN COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 32: POLAND COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 33: BELGIUM COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 34: REST OF EUROPE COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 35: ASIA-PACIFIC COUGH SYRUP MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 36: CHINA COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 37: JAPAN COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 38: INDIA COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 39: SOUTH KOREA COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 40: INDONESIA COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 41: THAILAND COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 42: VIETNAM COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 43: AUSTRALIA & NEW ZEALAND COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 44: REST OF ASIA-PACIFIC COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 45: REST OF WORLD COUGH SYRUP MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)

FIGURE 46: LATIN AMERICA COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 47: MIDDLE EAST & AFRICA COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FAQ’s

FAQs

Cough syrups’ side effects can vary depending on the active ingredients in the cough syrup and individual factors such as allergies and sensitivities. Some side effects include drowsiness, dizziness, upset stomach, or allergic reactions.

Yes, there are seasonal swings in the cough syrup business, with increasing demand during the cold and flu seasons.

Request Customization
Request Customization
Request free sample